Best AI Tool for a Systematic Review in 2026: What Each One Actually Does

What counts as a systematic review, and why does that change which tool you need?

A systematic review answers one question that was specified in advance, by searching for every study that meets eligibility criteria set before screening starts, screening all records against those criteria, and reporting the whole process in enough detail that another team could repeat it. That last clause is what separates it from an ordinary literature review, and it is why tool choice matters more here than anywhere else in academic writing.

The reporting standard most journals expect is PRISMA 2020, published by Page and colleagues in the BMJ in 2021. The PRISMA 2020 checklist "includes seven sections with 27 items, some of which include sub-items", covering the search, the selection process, the data collection, the risk of bias assessment and the synthesis. A tool that speeds up one of those 27 items has helped with roughly 4% of the reporting burden, which is worth having and is not the same as doing the review.

The conduct standard, if you are following Cochrane, is stricter. Cochrane’s MECIR standard C39 is marked Mandatory and reads: "Use (at least) two people working independently to determine whether each study meets the eligibility criteria, and define in advance the process for resolving disagreements." Two people. That single sentence rules out any tool as a complete answer, and it is the fact most tool comparisons leave out.

Which AI tool should I use for each stage of a systematic review?

Match the tool to the stage. Screening tools handle volume and disagreement between reviewers, research assistants handle discovery and extraction, and drafting tools handle the written synthesis at the end. Prices in this table are as of September 2026 and were read off each product’s own pricing page, linked in the first column. Vendors reprice without notice, so treat every figure below as a pointer to the page rather than a promise.

Two of those rows are the ones postgraduate students skip and then regret. Rayyan’s free plan covers three active reviews, which is more than most Masters students will run at once. Covidence’s pricing is built for funded teams, so a solo student paying $339 USD out of pocket for one review should look hard at whether Rayyan’s free tier does the same job.

Can an AI tool screen my abstracts instead of a second human?

Not in a review that follows Cochrane’s standards. MECIR standard C39 is Mandatory and requires "(at least) two people working independently" on eligibility decisions, and a language model is not a person under that standard. You can run an AI screener alongside two humans as a check, and some teams do, but it does not fill one of the two seats.

The performance data supports the caution rather than contradicting it. Kim and colleagues, writing in the Journal of Medical Artificial Intelligence in 2025, identified "a total of 15 LLM-based model performances" for title and abstract screening and reported a pooled area under the curve of 0.922 with sensitivity of 0.812 and a 95% confidence interval running from 0.617 to 0.920. Worth noting the authors’ own caveat: the pooled summary "does not reflect all models that are reported in literature due to a lack of information to discern the confusion matrix", so the pool is a subset of the 15.

At the point estimate, roughly one relevant record in five is missed. At the lower bound of that interval, nearly four in ten are missed. In a review where one missed trial can flip the direction of a pooled effect, that is a real cost, and it is why our guide to screening 500 abstracts treats AI relevance ranking as an ordering tool rather than a decision tool.

Is Elicit good enough for a systematic review on its own?

Elicit is the strongest of the AI research assistants for finding and extracting, and Elicit’s own documentation is clear about what it does: "Elicit screens every gathered paper against your criteria. A paper that fails any one of them is excluded, and every decision shows the quote from the paper behind it." Showing the quote behind each decision is a good design choice, because it makes an exclusion auditable.

The limits sit in that same documentation, and they matter for a systematic review specifically. Elicit’s Pro plan screens up to 5,000 gathered papers, Scale goes to 20,000 and Enterprise to 40,000, and the final report is built from "the 80 papers with the highest screening scores by default", which Pro can extend to 135 and Scale or Enterprise to 200. A report drawn from the highest scoring papers is a useful research output and it is not a synthesis of every included study, which is what a systematic review has to be.

Elicit also states on its own pages that it can save a large share of the time usually spent on a systematic review, and lists PRISMA grade screening and extraction accuracy as an Enterprise feature. Those are the vendor’s claims on the vendor’s site, which is exactly how to weigh them when writing a methods section. One more distinction worth being pedantic about, because it is the element people get wrong: Elicit does accept your own uploaded PDFs, so uploading is not what separates these tools. What differs is the output format, which is reports, tables and structured comparisons rather than prose.

What is the cheapest way to run a systematic review with AI in 2026?

A solo postgraduate student can assemble a working stack for nothing, as of September 2026. Rayyan gives a free forever plan with 3 active reviews and 2 invited reviewers, which covers screening and the second reviewer workflow. Research Rabbit is free to sign up and covers citation chaining. Consensus has a free tier for scoping the question. Scite gives 25 MCP credits a month on its free tier, though Assistant and Search are not included at that level. Litrevu gives 2,000 words free with no credit card, which is enough to see what a drafted section looks like.

The first thing worth paying for is usually screening capacity, not drafting. If a review is larger than Rayyan’s free tier comfortably handles, or a team needs risk of bias tooling, Covidence at $339 USD per year for a single review is the standard next step. If the constraint is the writing rather than the screening, the economics run the other way, because Litrevu’s paid tiers are one time purchases rather than monthly subscriptions: Starter is $8.49 for 7,500 words, Scholar is $29 for one complete cited draft with up to 500 sources. A student who needs the tool for six weeks pays once rather than six times.

Set your inclusion and exclusion criteria and your search strategy before paying for anything. Tools are cheap compared with the cost of screening 2,000 records against criteria that had to be revised halfway through.

Do I have to declare that I used AI in my systematic review?

Yes, and the expectation is now formal. On 11 November 2025, Cochrane, the Campbell Collaboration, JBI and the Collaboration for Environmental Evidence published a joint position statement on AI use in evidence synthesis that calls for "human oversight, transparency, and justification when AI is used in evidence synthesis". The statement sits on top of the RAISE recommendations, short for Responsible AI in Evidence Synthesis, released as three guidance papers in June 2025: one on collaboration across roles, one for developers building and evaluating AI tools, and one for users selecting and implementing them.

In practice that means three elements in a student’s methods section: name the tool and version, say which stage it was used for, and say who checked the output. Cochrane’s own stated goal is that AI enhances rather than replaces human judgement in the review process, and that authors are accountable for the final content. Institutional rules sit on top of that and differ by university and by country, so read your own institution’s research integrity policy alongside the target journal’s.

Where does Litrevu fit in a systematic review?

Litrevu handles the drafting stage only, after screening is finished and the included studies are settled. Litrevu is an AI literature review assistant that turns the papers a researcher has already gathered into a cited first draft, with every citation traceable to the uploaded source. It does not search databases, does not deduplicate records, does not screen against eligibility criteria, does not produce a PRISMA flow count, and does not act as a second reviewer under Cochrane MECIR standard C39.

What that leaves is the part most students find slowest: turning a folder of included PDFs into thematic prose where every claim points at a source. You upload the papers you have already included, Litrevu drafts the synthesis section by section, and each claim carries the citation for the uploaded paper it came from, so you can check it against the page. Whether that is worth having depends on where your bottleneck sits. If the bottleneck is screening, a screening tool will help more.

Here is the shape of a drafted section. This is a format illustration, not a real Litrevu result, and the bracketed tokens are placeholders rather than findings:

Theme 2: [Theme name]

Several of the included studies report [finding] (Author, Year; Author, Year). [Author, Year] reached a different conclusion, which the authors attribute to [stated reason]. Across this set, [gap] is not addressed directly by any of the included studies.

Source trace: (Author, Year), p. [page], from [filename].pdf

The point of the trace line is that you can open the PDF you uploaded and check the page. That check is your job, not the tool’s, and in a systematic review it is not optional.

Frequently asked questions

Can I just use ChatGPT to do my systematic review?

No. A general chatbot has no eligibility screening workflow, no duplicate detection, no audit trail of inclusion decisions, and no reliable link between a claim and the paper it came from. Cochrane’s MECIR standard C39 requires at least two people working independently on eligibility decisions, which a chatbot cannot satisfy. Use purpose built tools for screening and keep the human decisions human.

Is Elicit or Rayyan better for screening abstracts?

Rayyan is better for screening as a workflow, because it is built around multiple reviewers, duplicate detection and conflict resolution, and its free forever plan covers 3 active reviews with 2 invited reviewers. Elicit is better at finding papers and extracting structured data from them, and its Pro plan screens up to 5,000 gathered papers against criteria you set. Many teams use Elicit to find and extract, and Rayyan to screen.

Do I need Covidence if I am a solo Masters student?

Usually not. Covidence is priced for funded teams at $339 USD per year for a single review as of September 2026, and its strengths are team screening, risk of bias tooling and full text management at scale. A solo student running one review will typically get what they need from Rayyan’s free forever plan, which allows 3 active reviews. Consider Covidence when your department already holds a licence or when your supervisor requires it.

Will my university reject a systematic review that used AI?

Almost certainly not if you declare it properly, though the rule differs by institution and by country. The joint position statement published by Cochrane, the Campbell Collaboration, JBI and the Collaboration for Environmental Evidence on 11 November 2025 calls for human oversight, transparency and justification rather than prohibition. Name the tool, name the stage it was used for, and name who verified the output in your methods section, then check your own institution’s research integrity policy for anything stricter.

Does an AI screener count as my second reviewer?

No. Cochrane’s MECIR standard C39 is Mandatory and requires "(at least) two people working independently" to decide whether each study meets the eligibility criteria. An AI screener can run alongside two human screeners as an extra check, or as a way to order records by likely relevance, but it does not fill one of the two required seats. Pooled sensitivity for language model screening was reported at 0.812 in a 2025 meta-analysis in the Journal of Medical Artificial Intelligence, with a confidence interval reaching down to 0.617.

Can Litrevu run a systematic review for me?

No, and Litrevu does not claim to. Litrevu drafts the written synthesis from papers you have already searched for, screened and included, with each citation traceable to the PDF you uploaded. The search, the screening, the eligibility decisions, the PRISMA flow count and the verification of every citation remain yours.